Business
Easton Pharmaceuticals Provides Update On its Licensed Women's Diagnostics Products (VS-Sense, AL-Sense) and Other Updates
Easton Pharmaceuticals Provides Update On its Licensed Women's Diagnostics Products (VS-Sense, AL-Sense) and Other Updates.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Provides Update On its Licensed Women's Diagnostics Products (VS-Sense, AL-Sense) and Other Updates\n \n \nEaston Pharmaceuticals Provides Update On its Licensed Women's Diagnostics Products (VS-Sense, AL-Sense) and Other Updates\n \n TORONTO, ON--(Marketwired - Feb 8, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) provides contract negotiation update on the company's licensed women's diagnostics products (VS-Sense, AL-Sense) and update on its investment in AMFIL.\n Easton has been in negotiations for both its licensed AL-Sense and VS-Sense women's diagnostic products which are now considered final late stage negotiations. On Wednesday, February 8th, both BMV Medica and Easton Pharmaceuticals will be meeting in New York City with a multi-billion dollar revenue generating, multi-national pharmaceutical company who have been in negotiations with Easton / BMV and are intent on entering into a distribution agreement for AL-Sense (Amniotic Fluid Test) for Mexico and most of Latin America. A final agreement is imminent between Easton / BMV and the pharmaceutical company in question. Additional detailed updates are expected to be provided shortly.\n AL-Sense, also known as the Amniotic Fluid test, is intended for pregnant women, mainly in late-stage pregnancy, to enable them to detect the difference between an Amniotic Fluid leak which would necessitate a doctor's visit (as labour has started) and a simple urine leak. The test may also be used by High Risk pregnant women to monitor for Amniotic Fluid leaks beginning at earlier stages of pregnancy. This test is a state-of the art diagnostic test, which is in the form of a panty liner, and undergoes a simple color change if the wetness experienced by the pregnant woman is caused by an Amniotic Fluid leak. The relatively low cost and ease of use is expected to quickly become the test of choice for both women at home and in hospital use.\n This test has been endorsed by NHS (National Health Service) in Britain as part of the NICE report (National Institute for Health and Care Excellence), which indicates that the device can reliably exclude Amniotic Fluid leak as a cause of vaginal wetness in pregnancy, avoiding the need for a speculum examination and its associated discomforts. Using the device in the community could prevent unnecessary referrals to ...